Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)
|
November 6, 2025
Expert Opinion to Optimize Clinical Outcomes of Bimatoprost Intracameral Implant Treatment
Courtney Bovee, Jason Bacharach, Inder Paul Singh, et al.
American Journal of Ophthalmology
|
February 23, 2024
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Jason Bacharach, Jacob W Brubaker, David G Evans, et al.
Investigative Ophthalmology & Visual Science
|
June 9, 2016
Impact of Dry Eye Disease on Work Productivity, and Patients' Satisfaction With Over-the-Counter Dry Eye Treatments
Kelly K Nichols, Jason Bacharach, Edward Holland, et al.
Ophthalmology and Therapy
|
July 10, 2024
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Jason Bacharach, Long V Doan, Kerry G Stephens, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 17, 2018
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
Joseph Tauber, Barry A Schechter, Jason Bacharach, et al.
Journal of Glaucoma
|
September 15, 2025
Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled Trial
Eydie Miller-Ellis, James H Peace, Douglas G Day, et al.
Journal of Glaucoma
|
September 9, 2005
A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension
Bret A Hughes, Jason Bacharach, E Randy Craven, et al.
Ophthalmology
|
November 8, 2018
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial
Robert N Weinreb, Jason Bacharach, Robert D Fechtner, et al.
Journal of Glaucoma
|
May 12, 2023
Negative Pressure Application via a Multi-Pressure Dial to Lower IOP in Patients with Suspected Glaucoma or Open Angle Glaucoma
Thomas W Samuelson, Tanner J Ferguson, Jacob W Brubaker, et al.
American Journal of Ophthalmology
|
March 14, 2019
Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Albert S Khouri, Janet B Serle, Jason Bacharach, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Clinical Ophthalmology (Auckland, N.Z.)
|
November 6, 2025
Expert Opinion to Optimize Clinical Outcomes of Bimatoprost Intracameral Implant Treatment
Courtney Bovee, Jason Bacharach, Inder Paul Singh, et al.
American Journal of Ophthalmology
|
February 23, 2024
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Jason Bacharach, Jacob W Brubaker, David G Evans, et al.
Investigative Ophthalmology & Visual Science
|
June 9, 2016
Impact of Dry Eye Disease on Work Productivity, and Patients' Satisfaction With Over-the-Counter Dry Eye Treatments
Kelly K Nichols, Jason Bacharach, Edward Holland, et al.
Ophthalmology and Therapy
|
July 10, 2024
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Jason Bacharach, Long V Doan, Kerry G Stephens, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 17, 2018
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
Joseph Tauber, Barry A Schechter, Jason Bacharach, et al.
Journal of Glaucoma
|
September 15, 2025
Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled Trial
Eydie Miller-Ellis, James H Peace, Douglas G Day, et al.
Journal of Glaucoma
|
September 9, 2005
A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension
Bret A Hughes, Jason Bacharach, E Randy Craven, et al.
Ophthalmology
|
November 8, 2018
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial
Robert N Weinreb, Jason Bacharach, Robert D Fechtner, et al.
Journal of Glaucoma
|
May 12, 2023
Negative Pressure Application via a Multi-Pressure Dial to Lower IOP in Patients with Suspected Glaucoma or Open Angle Glaucoma
Thomas W Samuelson, Tanner J Ferguson, Jacob W Brubaker, et al.
American Journal of Ophthalmology
|
March 14, 2019
Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Albert S Khouri, Janet B Serle, Jason Bacharach, et al.
Page
of 5